Clinical Trials Logo

Lung Cancer Recurrent clinical trials

View clinical trials related to Lung Cancer Recurrent.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT03721133 Enrolling by invitation - Clinical trials for Lung Cancer Recurrent

Recurrent Predictive Power of Circulating Tumor Cells for Non Small Cell Lung Cancer Patients

Start date: December 4, 2018
Phase:
Study type: Observational

From literature review, circulating tumor cell was demonstrated its possible role in disease relapse. It was rare nit could be identified in all lung cancer patients. In addition, circulating tumor cell usual aggregate to form circulating tumor micro-emboli and caused distant metastases. Therefore, circulating tumor cell could play a role in detect disease relapse and appropriate treatment could be given more earlier and further prolong patients' survival. However, the detail clinical significance of circulating tumor still remains unknown. The aim of this study was evaluate the clinical significance, including present timing, numbers, and correlation to disease relapse, of circulating tumor cell in lung cancer patients. The investigators want to clarify the clinical significance between circulating tumor cell and clinical presentation of lung cancer in order to establish new prediction model and improve lung cancer patients' survival.